advertisement

Topcon

Pahlitzsch M 9

Showing records 1 to 9 | Display all abstracts from Pahlitzsch M

106060 Stabilization of macular, peripapillary and papillary vascular parameters after XEN and trabeculectomy visualized by the optical coherence tomography angiography
Reitemeyer E
Scientific reports 2022; 12: 17251
106182 XEN® implantation: an effective strategy to stop glaucoma progression despite prior minimally invasive glaucoma surgery
Davids AM
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 0: 1-10
106060 Stabilization of macular, peripapillary and papillary vascular parameters after XEN and trabeculectomy visualized by the optical coherence tomography angiography
Pahlitzsch M
Scientific reports 2022; 12: 17251
106182 XEN® implantation: an effective strategy to stop glaucoma progression despite prior minimally invasive glaucoma surgery
Pahlitzsch M
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 0: 1-10
106060 Stabilization of macular, peripapillary and papillary vascular parameters after XEN and trabeculectomy visualized by the optical coherence tomography angiography
Cornelius A
Scientific reports 2022; 12: 17251
106182 XEN® implantation: an effective strategy to stop glaucoma progression despite prior minimally invasive glaucoma surgery
Bertelmann E; Maier AK
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 0: 1-10
106060 Stabilization of macular, peripapillary and papillary vascular parameters after XEN and trabeculectomy visualized by the optical coherence tomography angiography
Pilger D
Scientific reports 2022; 12: 17251
106182 XEN® implantation: an effective strategy to stop glaucoma progression despite prior minimally invasive glaucoma surgery
Winterhalter S
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 0: 1-10
106060 Stabilization of macular, peripapillary and papillary vascular parameters after XEN and trabeculectomy visualized by the optical coherence tomography angiography
Winterhalter S; Maier AB
Scientific reports 2022; 12: 17251

Issue 23-3

Change Issue


advertisement

Oculus